Abstract
Intravesical oxybutynin hydrochloride was administered to 17 patients with a neuropathic bladder (myelomeningocele in 15 and spinal cord tumour in two) and urinary incontinence refractory to intermittent catheterisation. Therapy consisted of instillation of a 10 ml solution containing 5 mg oxybutynin hydrochloride twice daily. The cystometric bladder capacity before and after 1 hour of intravesical oxybutynin hydrochloride was 132 ± 45 ml and 193 ± 71 ml (mean ± 1 standard deviation, p < 0.01) in all 17 patients. In 13 patients with low compliant bladders, the mean bladder compliance before and after 1 hour of instillation was 4.2 ± 2.4ml/cmH2O and 8.5 ± 6.4ml/cmH2O respectively (p < 0.01). The period of the intravesical oxybutynin hydrochloride treatment ranged from 2 to 16 months (mean 11.1 months). The improvement rate of 'moderately improved' and better response was 76.5% in all 17 patients. One patient complained of slight lower abdominal pain, which receded as treatment continued. Since the pH value of the solution appeared to be so low as to irritate the vesical mucosa, the value was adjusted to 5.85. No local or systemic side effects were observed thereafter. These encouraging results suggest that intravesical instillation of oxybutynin hydrochloride is an attractive alternative in patients with a neuropathic bladder, who are either unresponsive to or have intolerable side effects from oral medications.
Similar content being viewed by others
Article PDF
References
Lapides J, Diokno A C, Silber S J, Lowe B S (1972) Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107: 458–461.
Brendler C B, Radebaugh L C, Mohler J L (1989) Topical oxybutynin chloride for relaxation of dysfunctional bladders. J Urol 141: 1350–1352.
Madersbacher H, Jilg G (1991) Control of detrusor hyperreflexia by the intravesical instillation of oxybutynin hydrochloride. Paraplegia 29: 84–90.
Greenfield S P, Fera M (1991) The use of intravesical oxybutynin chloride in children with neurogenic bladder. J Urol 146: 532–534.
Massad C A, Kogan B A, Trigo-Rocha F E (1992) The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol 148: 595–597.
Mohler J L (1990) Relaxation of intestinal bladders by intravesical oxybutynin chloride. Neurourol Urodynam 9: 179–187.
Lish P M, La Budde J A, Peeters E L, Robbins S I (1967) Oxybutynin, a musculotropic antispasmodic drug with moderate anticholinergic action. Arch Int Pharmacodyn Ther 156: 467–488.
Diokno A C, Lapides J (1972) Oxybutynin: A new drug with analgesic and anticholinergic properties. J Urol 108: 307–309.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mizunaga, M., Miyata, M., Kaneko , S. et al. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder. Spinal Cord 32, 25–29 (1994). https://doi.org/10.1038/sc.1994.5
Issue Date:
DOI: https://doi.org/10.1038/sc.1994.5
Keywords
This article is cited by
-
Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: a systematic review and meta-analysis
International Urology and Nephrology (2022)
-
Intérêt des thérapies intravésicales en neuro-urologie
Acta Endoscopica (2009)
-
Les thérapies intravésicales en neuro-urologie
Pelvi-périnéologie (2007)
-
Intravesical oxybutynin for spinal cord injury patients
Spinal Cord (1996)